Cargando…
Genetic variations in catechol-O-methyltransferase gene are associated with levodopa response variability in Chinese patients with Parkinson’s disease
Catechol-O-methyltransferase (COMT) is one of the main enzymes in dopamine metabolism and is reported to be associated with susceptibility to Parkinson’s disease (PD) and pharmacotherapy. However, researchers mostly focus on the most common polymorphism, rs4680. In this case-control study, we invest...
Autores principales: | Zhao, Cuiping, Wang, Yihua, Zhang, Bin, Yue, Yaoxian, Zhang, Jianyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293305/ https://www.ncbi.nlm.nih.gov/pubmed/32533012 http://dx.doi.org/10.1038/s41598-020-65332-2 |
Ejemplares similares
-
Opicapone Pharmacokinetics and Effects on Catechol-O-Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa
por: LeWitt, Peter, et al.
Publicado: (2023) -
Roles of functional catechol-O-methyltransferase genotypes in Chinese patients with Parkinson’s disease
por: Xiao, Qin, et al.
Publicado: (2017) -
The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
por: Leta, Valentina, et al.
Publicado: (2023) -
Depression and Catechol-O-methyltransferase (COMT) genetic variants are associated with pain in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017) -
Genetics of headache and catechol–O–methyltransferase gene polymorphism
por: Bayazit, Yildirim A.
Publicado: (2006)